Chris Viehbacher

Christopher Viehbacher serves as a member of Braveheart Bio’s board of directors and Chairman of the board of directors. Currently, Mr. Viehbacher is the President, Chief Executive Officer and a member of the board of directors of Biogen Inc. (Nasdaq: BIIB). Mr. Viehbacher was the co-founder and managing partner at Gurnet Point Capital LLC, a Cambridge-based healthcare investment fund. Prior to that, he was the Global Chief Executive Officer at Sanofi S.A. (Nasdaq: SNY) and started his career at GlaxoSmithKline plc (NYSE: GSK), where he held various roles.

‍

Mr. Viehbacher is a Trustee of Northeastern University, a member of the Board of Fellows of the Stanford Medical School and a member of the MIT President's CEO Advisory Board. Mr. Viehbacher holds a B.Comm from Queen's University, Kingston, Canada.

‍